366 related articles for article (PubMed ID: 12171824)
1. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
[TBL] [Abstract][Full Text] [Related]
2. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
Leach CL; Colice GL
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
[TBL] [Abstract][Full Text] [Related]
3. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
Leach CL; Davidson PJ; Boudreau RJ
Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
[TBL] [Abstract][Full Text] [Related]
4. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
[TBL] [Abstract][Full Text] [Related]
5. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
Seale JP; Harrison LI
Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
[TBL] [Abstract][Full Text] [Related]
6. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
Davies RJ; Stampone P; O'Connor BJ
Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
[TBL] [Abstract][Full Text] [Related]
7. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model.
Janssens HM; De Jongste JC; Hop WC; Tiddens HA
Chest; 2003 Jun; 123(6):2083-8. PubMed ID: 12796192
[TBL] [Abstract][Full Text] [Related]
8. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
9. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ; Orr LC; Wilson AM; Sims EJ; Lipworth BJ
Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG; Millar AB; Sykes AP
Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[TBL] [Abstract][Full Text] [Related]
12. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
Richards J; Hirst P; Pitcairn G; Mahashabde S; Abramowitz W; Nolting A; Newman SP
J Aerosol Med; 2001; 14(2):197-208. PubMed ID: 11681651
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ
Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
[TBL] [Abstract][Full Text] [Related]
14. Improved delivery of inhaled steroids to the large and small airways.
Leach CL
Respir Med; 1998 Jun; 92 Suppl A():3-8. PubMed ID: 9850357
[TBL] [Abstract][Full Text] [Related]
15. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD; Walters EG
Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
[TBL] [Abstract][Full Text] [Related]
16. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
Micheletto C; Guerriero M; Tognella S; Dal Negro RW
Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
[TBL] [Abstract][Full Text] [Related]
17. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
Thompson PJ; Davies RJ; Young WF; Grossman AB; Donnell D
Respir Med; 1998 Jun; 92 Suppl A():33-9. PubMed ID: 9850361
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate.
Lipworth BJ; Jackson CM
Br J Clin Pharmacol; 1999 Dec; 48(6):866-8. PubMed ID: 10594492
[TBL] [Abstract][Full Text] [Related]
19. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
Gross G; Thompson PJ; Chervinsky P; Vanden Burgt J
Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M; Wettenger R; Gans SJ
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
